We identified the precise mechanism by which the HIF/EHD2 pathway supports macropinocytosis-mediated metabolic reprogramming in cancer, providing an important molecular basis for the design of innovative cancer-therapeutic strategies against macropinocytosis. Here, EHD2 is linked to cancer.